HealthDay (7/18, Preidt) reports that almost three dozen experimental Alzheimer’s medicines are expected to begin clinical trials over the next five years, according to an analysis scheduled for presentation at the Alzheimer’s Association International Conference. No medications have been approved to treat Alzheimer’s in the US since 2003.
Related Links:
— “Dozens of Potential Alzheimer’s Meds in the Pipeline,” Robert Preidt, HealthDay, July 18, 2017.